Abstract:Actinomycetes have long been recognized as an important source of antibacterial natural products. In recent years, actinomycetes in extreme environments have become one of the main research directions. Streptomyces sp. KN37 was isolated from the cold region of Kanas in Xinjiang. It demonstrated potent antimicrobial activity, but the primary active compounds remained unclear. Therefore, we aimed to combine genomics with traditional isolation methods to obtain bioactive compounds from the strain KN37. Whole-genome sequencing and KEGG enrichment analysis indicated that KN37 possesses the potential for synthesizing secondary metabolites, and 41 biosynthetic gene clusters were predicted, some of which showed high similarity to known gene clusters responsible for the biosynthesis of antimicrobial antibiotics. The traditional isolation methods and activity-guided fractionation were employed to isolate and purify seven compounds with strong bioactivity from the fermentation broth of the strain KN37. These compounds were identified as 4-(Diethylamino)salicylaldehyde (1), 4-Nitrosodiphenylamine (2), N-(2,4-Dimethylphenyl)formamide (3), 4-Nitrocatechol (4), Methylsuccinic acid (5), Phenyllactic acid (6) and 5,6-Dimethylbenzimidazole (7). Moreover, 4-(Diethylamino)salicylaldehyde exhibited the most potent inhibitory effect against Rhizoctonia solani, with an EC50 value of 14.487 mg/L, while 4-Nitrosodiphenylamine showed great antibacterial activity against Erwinia amylovora, with an EC50 value of 5.715 mg/L. This study successfully isolated several highly active antimicrobial compounds from the metabolites of the strain KN37, which could contribute as scaffolds for subsequent chemical synthesis. On the other hand, the newly predicted antibiotic-like substances have not yet been isolated, but they still hold significant research value. They are instructive in the study of active natural product biosynthetic pathways, activation of silent gene clusters, and engineering bacteria construction.

Novel antimicrobial metabolites produced by Sika deer-associated Actinomyces sp. JN411010.

Integrative Genomics and Bioactivity-Guided Isolation of Novel Antimicrobial Compounds from Streptomyces sp. KN37 in Agricultural Applications

Isolation and Structure Elucidation of New Metabolites from the Mariana-Trench-Associated Fungus Aspergillus Sp. SY2601.

Novel Antimycin Analogues with Agricultural Antifungal Activities from the Sponge-Associated Actinomycete <i>Streptomyces </i>sp. NBU3104

Investigation on Metabolites in Structure and Biosynthesis from the Deep-Sea Sediment-Derived Actinomycete Janibacter sp. SCSIO 52865

Secondary Metabolites with Anti-Inflammatory Activities from One Actinobacteria Amycolatopsis taiwanensis

Three New Compounds from the Actinomycete Actinocorallia Aurantiaca

New analogues of amides and quinolinones produced by Streptomyces sp. YIM S01983

Antibacterial Metabolites from the Soil-Derived Actinobacteria Streptomyces Sp.

Antimicrobial Metabolites from a Novel Halophilic Actinomycete Nocardiopsis Terrae YIM 90022.

Metabolites Of Streptomyces Sp., An Endophytic Actinomycete From Alpinia Oxyphylla

New secondary metabolites from an engineering mutant of endophytic Streptomyces sp. CS

Diverse Secondary Metabolites from a Lichen-Derived Amycolatopsis Strain

Exploration of Diverse Secondary Metabolites From Streptomyces sp. YINM00001, Using Genome Mining and One Strain Many Compounds Approach

Baoshanmycin and a New Furanone Derivative from a Soil-Derived Actinomycete, <i>Amycolatopsis</i> sp. YNNP 00208

Antibacterial Metabolites from the Actinomycete Streptomyces Sp. P294

Antimicrobial metabolites from endophytic Streptomyces sp. YIM61470.

Isolation and Characterization of Two Novel Antibacterial Cyclic Hexapeptides from Streptomyces Alboflavus 313.

Antibiofilm Metabolites from Marine-derived Streptomyces sp. ZS-A31

Antibacterial metabolites from the fermentation broth of marine fungus 095407

Antimicrobial Metabolites from the Plant Endophytic Fungus Penicillium Sp.